Fig 1.
Median and range steady state erlotinib plasma concentrations after 150 or 300 mg oral dose of erlotinib in non–small-cell lung cancer patients who are current smokers.
Official websites use .gov
A
.gov website belongs to an official
government organization in the United States.
Secure .gov websites use HTTPS
A lock (
) or https:// means you've safely
connected to the .gov website. Share sensitive
information only on official, secure websites.